Access to radiotherapy and its association with cancer outcomes in a high-income country: Addressing the inequity in Canada.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
12 2019
Historique:
received: 25 04 2019
revised: 03 08 2019
accepted: 07 09 2019
pubmed: 3 10 2019
medline: 26 5 2020
entrez: 3 10 2019
Statut: ppublish

Résumé

Canada is a high-income country with universal healthcare. In international comparisons, its overall level of access to radiotherapy appears sufficient. However, challenges exist due to Canada's large geographic area and small population density. The association between access and cancer outcomes nationally has not yet been described. We quantified geographic accessibility for 2012 using the linear distance from each Canadian health region centroid to the nearest radiotherapy center. We used geospatial analytic techniques to detect clusters of age-standardized all-cancer mortality-to-incidence ratios (MIRs) across health regions, from 2010-2012. Global ordinary least squares (OLS) and geographically-weighted regression (GWR) were conducted to examine relationships between distance and MIR, adjusting for sociodemographic factors. Median distance from health region centroid to nearest radiotherapy center was 101.73 km (range 1.14-2095.12). One cluster of worse outcomes (MIR range 0.45-0.88) involved most of northern Canada, with a second cluster of better outcomes (MIR range 0.40-0.41) in southern British Columbia. In both regression models, regions with longer distance to radiotherapy center (ß = 0.0001), increased smoking (ß = 0.002), and poorer food security (ß = -0.003) were significantly associated with worse outcomes (OLS R A clear north-south discordance in cancer outcomes exists in Canada, with poorer outcomes in the north, while radiotherapy centers are concentrated along the south. Increased distance to radiotherapy, along with other sociodemographic and health-system factors, are associated with poorer cancer outcomes. Our study could be replicated, particularly in other high-income countries, to help identify national patterns and regional disparities in access and outcomes.

Sections du résumé

BACKGROUND AND PURPOSE
Canada is a high-income country with universal healthcare. In international comparisons, its overall level of access to radiotherapy appears sufficient. However, challenges exist due to Canada's large geographic area and small population density. The association between access and cancer outcomes nationally has not yet been described.
MATERIALS AND METHODS
We quantified geographic accessibility for 2012 using the linear distance from each Canadian health region centroid to the nearest radiotherapy center. We used geospatial analytic techniques to detect clusters of age-standardized all-cancer mortality-to-incidence ratios (MIRs) across health regions, from 2010-2012. Global ordinary least squares (OLS) and geographically-weighted regression (GWR) were conducted to examine relationships between distance and MIR, adjusting for sociodemographic factors.
RESULTS
Median distance from health region centroid to nearest radiotherapy center was 101.73 km (range 1.14-2095.12). One cluster of worse outcomes (MIR range 0.45-0.88) involved most of northern Canada, with a second cluster of better outcomes (MIR range 0.40-0.41) in southern British Columbia. In both regression models, regions with longer distance to radiotherapy center (ß = 0.0001), increased smoking (ß = 0.002), and poorer food security (ß = -0.003) were significantly associated with worse outcomes (OLS R
CONCLUSIONS
A clear north-south discordance in cancer outcomes exists in Canada, with poorer outcomes in the north, while radiotherapy centers are concentrated along the south. Increased distance to radiotherapy, along with other sociodemographic and health-system factors, are associated with poorer cancer outcomes. Our study could be replicated, particularly in other high-income countries, to help identify national patterns and regional disparities in access and outcomes.

Identifiants

pubmed: 31575428
pii: S0167-8140(19)33093-2
doi: 10.1016/j.radonc.2019.09.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-55

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Jessica Chan (J)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada; Division of Human Health, International Atomic Energy Agency, Vienna, Austria; Department of Radiation Oncology, Amsterdam UMC - Vrije University Medical Center, The Netherlands. Electronic address: jchan207@uottawa.ca.

Alfredo Polo (A)

Division of Human Health, International Atomic Energy Agency, Vienna, Austria.

Eduardo Zubizarreta (E)

Division of Human Health, International Atomic Energy Agency, Vienna, Austria.

Jean-Marc Bourque (JM)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada; Division of Human Health, International Atomic Energy Agency, Vienna, Austria; Institute of Cancer Policy, Kings College London, United Kingdom.

Timothy P Hanna (TP)

Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, Canada.

Marc Gaudet (M)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada.

Kristopher Dennis (K)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada.

Michael Brundage (M)

Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, Canada.

Ben Slotman (B)

Department of Radiation Oncology, Amsterdam UMC - Vrije University Medical Center, The Netherlands.

May Abdel-Wahab (M)

Division of Human Health, International Atomic Energy Agency, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH